Jump to content

Generic Virus Thread


villakram

Recommended Posts

I feel fairly confident predicting how this will play out.

  • Be provided with info about vaccine supplies
  • Asked to keep it secret
  • Tell everyone anyway
  • Don't get told things in future
  • The English are so **** mean, DAE independent Scotland?

https://www.heraldscotland.com/news/19046339.sturgeon-says-will-publish-vaccine-supply-figures-wishes-uk/

Quote

NICOLA Sturgeon has said she will publish vaccine supply figures despite the UK Government previously asking that they be kept secret.

The First Minister signalled the figures will be published from next week "regardless of what they say" in a bid to increase transparency. 

It comes amid an ongoing row over the speed of Scotland's vaccine rollout.

Ms Sturgeon previously said UK ministers had a "hissy fit" over the publication of the data, and accused them of briefing "misleading figures on supply".

The Scottish Government removed its vaccine rollout plan from its website earlier this month.

The UK Government had raised concerns the document contained sensitive details of how many doses the UK is receiving.

A source was quoted as saying: "The reason we didn't want to publish these figures was because everyone in the world wants these vaccines.

"If other countries see how much we are getting, they are likely to put pressure on the drug firms to give them some of our allocation."

 

Link to comment
Share on other sites

Not approved yet, they’ve provided the results of the trials. Over to the regulator next.

Quote

UK phase three trials of the experimental Novavax COVID-19 vaccine have found it demonstrated 89.3% efficacy against the virus.

Preliminary analysis showed the new UK variant was detected in more than half of the coronavirus cases recorded in the trials, with the vaccine candidate shown to be 95.6% effective against the original strain and 85.6% effective against the variant.

The study involved more than 15,000 participants aged 18 to 84, with 27% aged over 65.

Prime minister Boris Johnson called the result "good news".

"Our medicines regulator will now assess the vaccine, which will be made in Teesside. If approved, we have 60 million doses on order," he said.

https://news.sky.com/story/covid-19-uk-trials-show-experimental-novavax-coronavirus-vaccine-is-893-effective-12201756

Link to comment
Share on other sites

1 minute ago, Genie said:

Hopefully some of the 60m are waiting in fridges for be released for use.

I don't think our supply of vaccines is an issue atm, our supply of staff qualified to administer them is a different issue

  • Like 1
Link to comment
Share on other sites

Made in the UK too

https://www.bbc.co.uk/news/uk-55850352

Covid-19: Novavax vaccine shows 89% efficacy in UK trials

The UK has secured 60m doses of the jab, which will be made in Teeside.

Quote

A new coronavirus vaccine has been shown to be 89.3% effective in large-scale UK trials.

The Novavax jab is the first to show in trials that it is effective against the new virus variant found in the UK, the BBC's medical editor Fergus Walsh said.

The PM welcomed the "good news" and said the UK's medicines regulator would now assess the vaccine.

The UK has secured 60 million doses of the jab, which will be made in Stockton-on-Tees in north-east England.

The doses are expected to be delivered in the second half of this year, if approved for use by the Medicines and Healthcare Products Regulatory Agency (MHRA), the government said.

The UK has so far approved three coronavirus vaccines for emergency use - one from Oxford University and AstraZeneca, another by Pfizer and BioNTech, and a third from drug firm Moderna.

 

  • Like 1
Link to comment
Share on other sites

Not going to be available till the second half of this year so not so exciting.  A hell of a lot of people will already be vaccinated by then. 

Probably more important if the current vaccines turn out to not be as effective as hoped, otherwise it will just be helping mop up less at risk groups. 

Link to comment
Share on other sites

11 hours ago, darrenm said:

Of course, everyone knows that human beings undergo a complete change of physiology when they turn 65 years old which means they are completely different to, say, a 60 year old.

I don't think that's a very sensib!e comment.

Link to comment
Share on other sites

I wonder why the delay. 

With the other vaccines it was a couple of weeks between them announcing their results and the peer review agreeing them and then about 2-3 weeks after that the MHRA gave approval. Deliveries started almost immediately after that, so I was expecting to hear that this vaccine would be available in a matter of weeks, but they are saying second half of the year. 

You would think they would crack on and get it rushed through. 

Link to comment
Share on other sites

To give you an idea about how well Boris's Christmas arrangements worked out?

4 week wait for a service at the crematorium in the Mids, and the local mosque here has put out a call to the public for assistance with their backlog, non Muslims welcomed.

  • Sad 1
Link to comment
Share on other sites

6 hours ago, Seat68 said:

Novavax is 2 dose, its the J&J single dose vaccine that needs to get a wiggle on. 

J & J is manufactured in Belgium so will probably be seized by local authorities to prevent its export from EU. 

This whole charade with AZ is choreographed to justify stealing the Pfizer vaccines UK has already purchased, as per Bild yesterday.

  • Like 1
Link to comment
Share on other sites

10 hours ago, snowychap said:

I don't think that's a very sensib!e comment.

Yes and no, IMO. Obviously Darren is being a bit flippant, but to take the point seriously, presumably there are fairly strong reasons to assume that a vaccine that works well among 50-somethings is going to work well among 70-somethings. Is there any reason for that not to be our prior, ie are there any examples of vaccines that are highly effective in the first group and completely ineffective for the latter? (That's a serious question, I'm not aware of any but happy to be shown they exist)

The matter of 'pulling out population subgroups and declaring there's an insufficient sample size' is theoretically infinite, so it seems important to establish there is actually a meaningful theoretical reason to need to establish efficacy in the over-65s.

Link to comment
Share on other sites

×
×
  • Create New...
Â